Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KMO | O15229 | 7/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25958491 | 0.84 | KDM4E (0.39) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL23989841 | 0.83 | KDM4E (0.36) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL1412495 | 0.80 | KDM4E (0.37) | NPC1RAB9AKDM4EPTGS2SMN1; SMN2 | |
| SCHEMBL23991151 | 0.80 | CNR1 (0.37) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL23985455 | 0.79 | KDM4C (0.34) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| Bicarbonate SCHEMBL7485088 | 0.75 | KDM4E (0.34) | NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL1412690 | 0.74 | KDM4E (0.42) | MAPK1NPC1RAB9AKDM4EPOLB | |
| SCHEMBL23989504 | 0.74 | GRM2 (0.39) | — | |
| SCHEMBL21281661 | 0.74 | KDM4E (0.31) | RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL28976518 | 0.73 | SMN1; SMN2 (0.33) | MAPK1RAB9AKDM4EPTGS2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2274296-A1 | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS | Merck Sharp & Dohme Corp. (US) | 2011-01-19 | — | — | EP | disclosed |